Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4208331
Max Phase: Preclinical
Molecular Formula: C27H32O6
Molecular Weight: 452.55
Molecule Type: Small molecule
Associated Items:
ID: ALA4208331
Max Phase: Preclinical
Molecular Formula: C27H32O6
Molecular Weight: 452.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(=O)O[C@@H]2C3=C(C)[C@@H](OC(=O)c4ccc(CCC)cc4)CC3[C@](C)(OC(C)=O)CC[C@@H]12
Standard InChI: InChI=1S/C27H32O6/c1-6-7-18-8-10-19(11-9-18)26(30)31-22-14-21-23(16(22)3)24-20(15(2)25(29)32-24)12-13-27(21,5)33-17(4)28/h8-11,20-22,24H,2,6-7,12-14H2,1,3-5H3/t20-,21?,22-,24-,27+/m0/s1
Standard InChI Key: AINHPYLGGCBFBD-DVAKBSPTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 452.55 | Molecular Weight (Monoisotopic): 452.2199 | AlogP: 4.71 | #Rotatable Bonds: 5 |
Polar Surface Area: 78.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.19 | CX LogD: 5.19 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.28 | Np Likeness Score: 2.15 |
1. Chen H, Yang X, Yu Z, Cheng Z, Yuan H, Zhao Z, Wu G, Xie N, Yuan X, Sun Q, Zhang W.. (2018) Synthesis and biological evaluation of α-santonin derivatives as anti-hepatoma agents., 149 [PMID:29499490] [10.1016/j.ejmech.2018.02.073] |
Source(1):